Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review

View ORCID ProfileBenjamin P. Geisler, Lara Zahabi, View ORCID ProfileAdam E. Lang, Naomi Eastwood, View ORCID ProfileElaine Tennant, View ORCID ProfileLjiljana Lukic, View ORCID ProfileElad Sharon, View ORCID ProfileHai-Hua Chuang, Chang-Berm Kang, Knakita Clayton-Johnson, View ORCID ProfileAhmed Aljaberi, Haining Yu, Chinh Bui, Tuan Le Mau, Wen-Cheng Li, View ORCID ProfileDebbie Teodorescu, View ORCID ProfileLudwig Christian Hinske, Dennis L. Sun, View ORCID ProfileFarrin A. Manian, View ORCID ProfileAdam G. Dunn
doi: https://doi.org/10.1101/2020.05.21.20109074
Benjamin P. Geisler
1Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
2Ludwig Maximilian University, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Benjamin P. Geisler
  • For correspondence: bgeisler@post.harvard.edu
Lara Zahabi
3McGill University, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam E. Lang
4McDonald Army Health Center, Fort Eustis, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adam E. Lang
Naomi Eastwood
5Wirral University Teaching Hospital NHS Foundation Trust, Wirral, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine Tennant
6Royal North Shore Hospital, Sydney, NSW, Australia
7University of New South Wales, Sydney, NSW, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elaine Tennant
Ljiljana Lukic
8University Hospital for Infectious Disease Zagreb “Dr. Fran Mihaljevic”, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ljiljana Lukic
Elad Sharon
9National Cancer Institute, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elad Sharon
Hai-Hua Chuang
10Chang Gung Memorial Hospital/Chang Gung University, Taoyuan, Taiwan
11National Taipei University of Technology, Taipei, Taiwan
12Geisinger Medical Center, Danville, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hai-Hua Chuang
Chang-Berm Kang
13Proof Biotechnologies, Inc., Columbia, SC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Knakita Clayton-Johnson
14Portmore Hospital Complex, Portmore, Jamaica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed Aljaberi
15Brigham and Women’s Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ahmed Aljaberi
Haining Yu
16University of California San Francisco Medical Center, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chinh Bui
17Massachusetts Institute for Technology, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tuan Le Mau
18Institute of High Performance Computing, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen-Cheng Li
10Chang Gung Memorial Hospital/Chang Gung University, Taoyuan, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debbie Teodorescu
1Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
17Massachusetts Institute for Technology, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Debbie Teodorescu
Ludwig Christian Hinske
2Ludwig Maximilian University, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ludwig Christian Hinske
Dennis L. Sun
19California Polytechnic State University, San Luis Obispo, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farrin A. Manian
1Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Farrin A. Manian
Adam G. Dunn
20University of Sydney, Sydney, NSW, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adam G. Dunn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Coronavirus Disease 2019 (COVID-19) has no known specific treatments. However, there might be in vitro and early clinical data as well as evidence from Severe Acute Respiratory Syndrome and Middle Eastern Respiratory Syndrome that could inform clinicians and researchers. This systematic review aims to create priorities for future research of drugs repurposed for COVID-19.

Methods This systematic review will include in vitro, animal, and clinical studies evaluating the efficacy of a list of 34 specific compounds and four groups of drugs identified in a previous scoping review. Studies will be identified both from traditional literature databases and pre-print servers. Outcomes assessed will include time to clinical improvement, time to viral clearance, mortality, length of hospital stay, and proportions transferred to the intensive care unit and intubated, respectively. We will use the GRADE methodology to assess the quality of the evidence.

Discussion The challenge posed by COVID-19 requires not just a rapid review of drugs that can be repurposed but also a sustained effort to integrate new evidence into a living systematic review.

Systematic review registration PROSPERO 2020 CRD42020175648

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No specific funding was available for this project.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N.A.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

For permanency, history will be kept and made permanently available via our website http://www.CovidDrugs.org. The completed review as well as intermittent updates (e.g., when the number of included studies changes, when a conclusion for any intervention changes, or upon some other well-defined trigger) will also be available via the pre-print server medRxiv.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted May 23, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review
Benjamin P. Geisler, Lara Zahabi, Adam E. Lang, Naomi Eastwood, Elaine Tennant, Ljiljana Lukic, Elad Sharon, Hai-Hua Chuang, Chang-Berm Kang, Knakita Clayton-Johnson, Ahmed Aljaberi, Haining Yu, Chinh Bui, Tuan Le Mau, Wen-Cheng Li, Debbie Teodorescu, Ludwig Christian Hinske, Dennis L. Sun, Farrin A. Manian, Adam G. Dunn
medRxiv 2020.05.21.20109074; doi: https://doi.org/10.1101/2020.05.21.20109074
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review
Benjamin P. Geisler, Lara Zahabi, Adam E. Lang, Naomi Eastwood, Elaine Tennant, Ljiljana Lukic, Elad Sharon, Hai-Hua Chuang, Chang-Berm Kang, Knakita Clayton-Johnson, Ahmed Aljaberi, Haining Yu, Chinh Bui, Tuan Le Mau, Wen-Cheng Li, Debbie Teodorescu, Ludwig Christian Hinske, Dennis L. Sun, Farrin A. Manian, Adam G. Dunn
medRxiv 2020.05.21.20109074; doi: https://doi.org/10.1101/2020.05.21.20109074

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4809)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (671)
  • Geriatric Medicine (70)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (85)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5280)
  • Intensive Care and Critical Care Medicine (326)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (110)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (438)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (768)
  • Public and Global Health (1798)
  • Radiology and Imaging (321)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (68)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)